These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9987499)

  • 1. [Difference in strategy for breast cancer between western countries and Japan].
    Saito M; Kasumi F
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):61-8. PubMed ID: 9987499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The differences of standard therapy for breast cancer between Europe/America and Japan--chemotherapy, operation,and radiotherapy].
    Kitagawa D; Saji S
    Gan To Kagaku Ryoho; 2007 May; 34(5):690-3. PubMed ID: 17496438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials.
    Taghian AG; Jeong JH; Mamounas EP; Parda DS; Deutsch M; Costantino JP; Wolmark N
    J Clin Oncol; 2006 Aug; 24(24):3927-32. PubMed ID: 16921044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
    Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J
    Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effective treatment strategy in elderly breast cancer patients].
    Boér K
    Orv Hetil; 2005 Jan; 146(1):15-21. PubMed ID: 15715368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of locally advanced breast cancer. Mini-review.
    Franceschini G; Terribile D; Fabbri C; Magno S; D'Alba P; Chiesa F; Di Leone A; Masetti R
    Minerva Chir; 2007 Aug; 62(4):249-55. PubMed ID: 17641585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment strategy for cancer of the colorectum--difference with western approach].
    Hojo K
    Gan To Kagaku Ryoho; 1998 Jul; 25(8):1123-30. PubMed ID: 9679573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Early-stage breast cancer - strategies for adjuvant systemic therapy].
    Görner M; Just M; Gerull S
    Handchir Mikrochir Plast Chir; 2008 Aug; 40(4):230-8. PubMed ID: 18716990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy for breast cancer--"one fits all"?
    Bergh J
    Breast; 2005 Dec; 14(6):564-9. PubMed ID: 16243525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update in the treatment of locally advanced breast cancer: a multidisciplinary approach.
    Franceschini G; Terribile D; Magno S; Fabbri C; D'Alba PF; Chiesa F; Di Leone A; Masetti R
    Eur Rev Med Pharmacol Sci; 2007; 11(5):283-9. PubMed ID: 18074936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress in breast cancer treatment over a quarter of a century].
    Tominaga T
    Gan To Kagaku Ryoho; 1999 Jun; 26 Suppl 1():99-109. PubMed ID: 10410664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
    Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Breast cancer].
    Ikeda T; Jinno H; Matsui A; Mitsui Y; Asaga S; Muto T; Wada M; Kitajima M
    Gan To Kagaku Ryoho; 2002 Sep; 29(9):1509-15. PubMed ID: 12355936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant systemic therapy for early breast cancer: progress and controversies.
    Hortobagyi GN
    Clin Cancer Res; 2001 Jul; 7(7):1839-42. PubMed ID: 11448893
    [No Abstract]   [Full Text] [Related]  

  • 16. [The importance of the type of surgical exeresis on survival in breast cancer. Possibility of polychemotherapy].
    Orecchia C; Sigaudo F; Ardizzone L; Ciconi E; Botta C; Cannata G; Capoluongo R; Grazioli O; Pasché P; Rosso G
    Minerva Chir; 1984 Apr; 39(8):623-6. PubMed ID: 6483230
    [No Abstract]   [Full Text] [Related]  

  • 17. [Timing of radiotherapy in the treatment of breast carcinoma. Review of the literature].
    Trovò MG; Gigante M; Roncadin M; Arcicasa M; Bortolus R
    Ann Ital Chir; 1999; 70(3):371-6. PubMed ID: 10466240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of breast cancer clinical trials conducted by the National Surgical Adjuvant Breast Project.
    Newman LA; Mamounas EP
    Surg Clin North Am; 2007 Apr; 87(2):279-305, vii. PubMed ID: 17498527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adjuvant therapy in breast cancer].
    Semiglazov VF
    Vopr Onkol; 2000; 46(1):18-27. PubMed ID: 10789218
    [No Abstract]   [Full Text] [Related]  

  • 20. [Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy].
    Straver ME; van Adrichem JC; Rutgers EJ; Rodenhuis S; Linn SC; Loo CE; Gilhuijs KG; Oldenburg HS; Wesseling J; Russell NS; Antonini N; Vrancken Peeters MT
    Ned Tijdschr Geneeskd; 2008 Nov; 152(46):2519-25. PubMed ID: 19055260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.